# Earli: Research, Redwood City, United States

> Earli: Earli is a biotechnology company founded in 2018 and based in Redwood City, California, with operations in South San Francisco.

Source: https://millionrounds.com/startup/earli (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Earli

Earli is a biotechnology company founded in 2018 and based in Redwood City, California, with operations in South San Francisco.

Funding reported Last round: Series A

Research Redwood City, United States

Company summary

- **Founded:** 2018 8 years old
- **Team:** 37 11 to 50 people
- **Funding reported:** $60M in dollars
- **Last round:** Series A Jan 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Earli has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Earli

Earli is a biotechnology company founded in 2018 and based in Redwood City, California, with operations in South San Francisco.

The company focuses on transforming cancer detection and treatment through its innovative Synthetic Biopsy technology. Earli's mission is to make cancer a benign experience by utilizing programmable genetic constructs that enable early detection and self-destruction of tumors. The Synthetic Biopsy platform allows for the detection of cancer at its earliest stages by forcing cancer cells to produce a synthetic biomarker, which can be identified in blood, urine, or breath samples. This technology not only aids in early detection but also facilitates precise localization of tumors using PET scans. Additionally, Earli integrates artificial intelligence to enhance the specificity and efficiency of its genetic constructs, ensuring targeted action against malignant cells while preserving healthy tissue. Earli collaborates with strategic partners and investors, including Accenture Ventures and Andreessen Horowitz, to advance its mission in the healthcare and oncology sectors. The company aims to improve patient outcomes by enabling personalized treatment and early detection of metastases.

## What company datasets say Earli raised

Funding, as reported

Reported in all **$60M** in dollars

Rounds **3**

Last round **Series A**

Last round date **Jan 2021**

Investors listed **23**

SEC Form D **$40M sold, 1 filing, last Jan 2021**

## Founders and team

From Earli's own website and the SEC filings it signed: 1 founder, 5 on the team.

**Cyriac Roeding** Co-Founder, *Named on its 2021 Form D*

- **David Suhy** Executive Officer, Director i
- **Dave Rosen** Team
- **Dr. Badri Ananthanarayanan** Team
- **Sashikanth Banappagari** Team
- **Stan Frankel** Team

On the board, as filed i *Jorge Conde* *Justin Kao*

## On 7 portfolio pages

Investors who name them

- [MBX Capital](https://millionrounds.com/fund/mbx-capital)
- [Breyer Capital](https://millionrounds.com/fund/breyer-capital)
- [What If Ventures](https://millionrounds.com/fund/what-if-ventures)
- [Han River Partners](https://millionrounds.com/fund/han-river-partners)
- [World Solver](https://millionrounds.com/fund/world-solver)
- [think.health](https://millionrounds.com/fund/think-health-ventures)
- [IKJ Capital](https://millionrounds.com/fund/ikj-capital)

Each firm lists Earli on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care synthetic biopsy cancer self-destruction molecular diagnostics biotechnology research cancer cell hijacking cancer therapy biotech funding therapeutic proteins medical research oncology research information technology & services oncology platform cancer early diagnosis hospital & health care cancer immunotherapy

Built with from their website

Amazon CloudFront Graphy Google Cloud Flow YouTube CloudFlare Viewport Meta.NET Webflow Hosting AI

+8 more

CloudFlare CDN Google Font API Microsoft Exchange Microsoft 365 Apps & Services Mobile Friendly Greenhouse CAT Open Graph

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** California
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/earli)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Earli in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)